Patient perspectives on buprenorphine/naloxone for chronic noncancer pain: A qualitative interview study
{{output}}
Background: Buprenorphine/naloxone (Suboxone) is an emerging option for chronic noncancer pain (CNCP), but evidence on transitioning patients from full opioid agonists remains limited. At the University of Saskatchewan Chronic Pa... ...